Seeking Alpha

Goldman Sachs weighs in on the pharmacy wars, noting CVS Caremark (CVS +2.2%) still has room to...

Goldman Sachs weighs in on the pharmacy wars, noting CVS Caremark (CVS +2.2%) still has room to grow based on its "distinctive positioning" in the sector. Despite all the sound and fury from Walgreen (WAG -0.1%) on recapturing its lost customers back, the opposite appears to be the reality as the CVS share in the prescription market rises instead of falls.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs